Global cfDNA Testing Supply, Demand and Key Producers, 2026-2032
The global cfDNA Testing market size is expected to reach $ 19925 million by 2032, rising at a market growth of 9.9% CAGR during the forecast period (2026-2032).
cfDNA testing is a precision medicine service that involves collecting human bodily fluid samples (such as blood or urine) to extract extracellular DNA fragments. By employing molecular detection technologies—including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis—these fragments are analyzed for gene mutations, chromosomal abnormalities, methylation patterns, and genomic information to facilitate disease screening, diagnosis, treatment monitoring, and prognostic assessment. cfDNA originates primarily from DNA released during normal cell apoptosis and from DNA shed by specialized tissues such as tumor cells and placental cells; tumor-derived cfDNA (ctDNA) is utilized for cancer liquid biopsies, while non-invasive prenatal testing (NIPT) screens for chromosomal abnormalities using fetal-derived cfDNA found in maternal blood. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, allowing for repeated sampling, and providing a real-time reflection of disease status, making it a key technological direction in liquid biopsy and precision medicine.
Driven by the rapid advancement of global precision medicine, liquid biopsy, and genetic testing technologies, the cfDNA testing market holds significant growth potential. In oncology, the rising demand for early cancer screening, monitoring of minimal residual disease (MRD), and companion diagnostics for targeted therapies has established ctDNA testing as a vital tool for precision diagnosis and treatment. In the field of obstetrics and gynecology, NIPT has emerged as one of the most commercially mature applications of cfDNA testing. Furthermore, new applications—such as organ transplant monitoring, genetic disease screening, and infectious disease detection—are continuously expanding. Looking ahead, as sequencing costs decrease, AI-assisted analysis capabilities improve, and testing standards are refined, cfDNA testing will evolve from single-disease detection toward multi-cancer early screening, dynamic health monitoring, and personalized treatment. The global cfDNA testing market is projected to maintain a compound annual growth rate (CAGR) of over 10%, positioning it as a rapidly growing segment within the molecular diagnostics industry.
This report is a detailed and comprehensive analysis of the world market for cfDNA Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of cfDNA Testing that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world cfDNA Testing market
2. What is the demand of the global cfDNA Testing market?
3. What is the year over year growth of the global cfDNA Testing market?
4. What is the total value of the global cfDNA Testing market?
5. Who are the Major Players in the global cfDNA Testing market?
6. What are the growth factors driving the market demand?
cfDNA testing is a precision medicine service that involves collecting human bodily fluid samples (such as blood or urine) to extract extracellular DNA fragments. By employing molecular detection technologies—including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis—these fragments are analyzed for gene mutations, chromosomal abnormalities, methylation patterns, and genomic information to facilitate disease screening, diagnosis, treatment monitoring, and prognostic assessment. cfDNA originates primarily from DNA released during normal cell apoptosis and from DNA shed by specialized tissues such as tumor cells and placental cells; tumor-derived cfDNA (ctDNA) is utilized for cancer liquid biopsies, while non-invasive prenatal testing (NIPT) screens for chromosomal abnormalities using fetal-derived cfDNA found in maternal blood. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, allowing for repeated sampling, and providing a real-time reflection of disease status, making it a key technological direction in liquid biopsy and precision medicine.
Driven by the rapid advancement of global precision medicine, liquid biopsy, and genetic testing technologies, the cfDNA testing market holds significant growth potential. In oncology, the rising demand for early cancer screening, monitoring of minimal residual disease (MRD), and companion diagnostics for targeted therapies has established ctDNA testing as a vital tool for precision diagnosis and treatment. In the field of obstetrics and gynecology, NIPT has emerged as one of the most commercially mature applications of cfDNA testing. Furthermore, new applications—such as organ transplant monitoring, genetic disease screening, and infectious disease detection—are continuously expanding. Looking ahead, as sequencing costs decrease, AI-assisted analysis capabilities improve, and testing standards are refined, cfDNA testing will evolve from single-disease detection toward multi-cancer early screening, dynamic health monitoring, and personalized treatment. The global cfDNA testing market is projected to maintain a compound annual growth rate (CAGR) of over 10%, positioning it as a rapidly growing segment within the molecular diagnostics industry.
Report Scope
This report studies the global cfDNA Testing demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for cfDNA Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of cfDNA Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global cfDNA Testing total market, 2021-2032, (USD Million)
- Global cfDNA Testing total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: cfDNA Testing total market, key domestic companies, and share, (USD Million)
- Global cfDNA Testing revenue by player, revenue and market share 2021-2026, (USD Million)
- Global cfDNA Testing total market by Type, CAGR, 2021-2032, (USD Million)
- Global cfDNA Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world cfDNA Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global cfDNA Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Global cfDNA Testing Market, Segmentation by Type:
- Targeted Sequencing
- Whole Genome Sequencing
Global cfDNA Testing Market, Segmentation by Test Type:
- Services
- Reagent Kits
- Others
Global cfDNA Testing Market, Segmentation Target Audiences:
- LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
- DTC (Direct-to-Consumer) Services for Consumers
Global cfDNA Testing Market, Segmentation by Application:
- Prenatal Testing
- Oncology
- Organ Transplant Monitoring
- Others
Companies Profiled:
- NIPT by LifeCodexx
- Genodive Pharma
- Riken Genesis
- GC Genome
- EDGC
- Natera
- CareDx
- BillionToOne, Inc.
- ARUP Laboratories
- Guardant Health
- GRAIL
- Foundation Medicine
- MedGenome
- Lucence
- BGI Genomics
- Berry Genomics
- Burning Rock
- ACT Genomics
Key Questions Answered
1. How big is the global cfDNA Testing market?2. What is the demand of the global cfDNA Testing market?
3. What is the year over year growth of the global cfDNA Testing market?
4. What is the total value of the global cfDNA Testing market?
5. Who are the Major Players in the global cfDNA Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 cfDNA Testing Introduction
1.2 World cfDNA Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World cfDNA Testing Total Market by Region (by Headquarter Location)
1.3.1 World cfDNA Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company cfDNA Testing Revenue (2021-2032)
1.3.3 China Based Company cfDNA Testing Revenue (2021-2032)
1.3.4 Europe Based Company cfDNA Testing Revenue (2021-2032)
1.3.5 Japan Based Company cfDNA Testing Revenue (2021-2032)
1.3.6 South Korea Based Company cfDNA Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company cfDNA Testing Revenue (2021-2032)
1.3.8 India Based Company cfDNA Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 cfDNA Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World cfDNA Testing Consumption Value (2021-2032)
2.2 World cfDNA Testing Consumption Value by Region
2.2.1 World cfDNA Testing Consumption Value by Region (2021-2026)
2.2.2 World cfDNA Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States cfDNA Testing Consumption Value (2021-2032)
2.4 China cfDNA Testing Consumption Value (2021-2032)
2.5 Europe cfDNA Testing Consumption Value (2021-2032)
2.6 Japan cfDNA Testing Consumption Value (2021-2032)
2.7 South Korea cfDNA Testing Consumption Value (2021-2032)
2.8 ASEAN cfDNA Testing Consumption Value (2021-2032)
2.9 India cfDNA Testing Consumption Value (2021-2032)
3 WORLD CFDNA TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World cfDNA Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global cfDNA Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for cfDNA Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for cfDNA Testing in 2025
3.3 cfDNA Testing Company Evaluation Quadrant
3.4 cfDNA Testing Market: Overall Company Footprint Analysis
3.4.1 cfDNA Testing Market: Region Footprint
3.4.2 cfDNA Testing Market: Company Product Type Footprint
3.4.3 cfDNA Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: cfDNA Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: cfDNA Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: cfDNA Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: cfDNA Testing Consumption Value Comparison
4.2.1 United States VS China: cfDNA Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: cfDNA Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based cfDNA Testing Companies and Market Share, 2021-2026
4.3.1 United States Based cfDNA Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies cfDNA Testing Revenue, (2021-2026)
4.4 China Based Companies cfDNA Testing Revenue and Market Share, 2021-2026
4.4.1 China Based cfDNA Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies cfDNA Testing Revenue, (2021-2026)
4.5 Rest of World Based cfDNA Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based cfDNA Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies cfDNA Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World cfDNA Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Sequencing
5.2.2 Whole Genome Sequencing
5.3 Market Segment by Type
5.3.1 World cfDNA Testing Market Size by Type (2021-2026)
5.3.2 World cfDNA Testing Market Size by Type (2027-2032)
5.3.3 World cfDNA Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEST TYPE
6.1 World cfDNA Testing Market Size Overview by Test Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Test Type
6.2.1 Services
6.2.2 Reagent Kits
6.2.3 Others
6.3 Market Segment by Test Type
6.3.1 World cfDNA Testing Market Size by Test Type (2021-2026)
6.3.2 World cfDNA Testing Market Size by Test Type (2027-2032)
6.3.3 World cfDNA Testing Market Size Market Share by Test Type (2027-2032)
7 MARKET ANALYSIS TARGET AUDIENCES
7.1 World cfDNA Testing Market Size Overview Target Audiences: 2021 VS 2025 VS 2032
7.2 Segment Introduction Target Audiences
7.2.1 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
7.2.2 DTC (Direct-to-Consumer) Services for Consumers
7.3 Market Segment Target Audiences
7.3.1 World cfDNA Testing Market Size Target Audiences (2021-2026)
7.3.2 World cfDNA Testing Market Size Target Audiences (2027-2032)
7.3.3 World cfDNA Testing Market Size Market Share Target Audiences (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World cfDNA Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Prenatal Testing
8.2.2 Oncology
8.2.3 Organ Transplant Monitoring
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World cfDNA Testing Market Size by Application (2021-2026)
8.3.2 World cfDNA Testing Market Size by Application (2027-2032)
8.3.3 World cfDNA Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 NIPT by LifeCodexx
9.1.1 NIPT by LifeCodexx Details
9.1.2 NIPT by LifeCodexx Major Business
9.1.3 NIPT by LifeCodexx cfDNA Testing Product and Services
9.1.4 NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 NIPT by LifeCodexx Recent Developments/Updates
9.1.6 NIPT by LifeCodexx Competitive Strengths & Weaknesses
9.2 Genodive Pharma
9.2.1 Genodive Pharma Details
9.2.2 Genodive Pharma Major Business
9.2.3 Genodive Pharma cfDNA Testing Product and Services
9.2.4 Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Genodive Pharma Recent Developments/Updates
9.2.6 Genodive Pharma Competitive Strengths & Weaknesses
9.3 Riken Genesis
9.3.1 Riken Genesis Details
9.3.2 Riken Genesis Major Business
9.3.3 Riken Genesis cfDNA Testing Product and Services
9.3.4 Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Riken Genesis Recent Developments/Updates
9.3.6 Riken Genesis Competitive Strengths & Weaknesses
9.4 GC Genome
9.4.1 GC Genome Details
9.4.2 GC Genome Major Business
9.4.3 GC Genome cfDNA Testing Product and Services
9.4.4 GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GC Genome Recent Developments/Updates
9.4.6 GC Genome Competitive Strengths & Weaknesses
9.5 EDGC
9.5.1 EDGC Details
9.5.2 EDGC Major Business
9.5.3 EDGC cfDNA Testing Product and Services
9.5.4 EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EDGC Recent Developments/Updates
9.5.6 EDGC Competitive Strengths & Weaknesses
9.6 Natera
9.6.1 Natera Details
9.6.2 Natera Major Business
9.6.3 Natera cfDNA Testing Product and Services
9.6.4 Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Natera Recent Developments/Updates
9.6.6 Natera Competitive Strengths & Weaknesses
9.7 CareDx
9.7.1 CareDx Details
9.7.2 CareDx Major Business
9.7.3 CareDx cfDNA Testing Product and Services
9.7.4 CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CareDx Recent Developments/Updates
9.7.6 CareDx Competitive Strengths & Weaknesses
9.8 BillionToOne, Inc.
9.8.1 BillionToOne, Inc. Details
9.8.2 BillionToOne, Inc. Major Business
9.8.3 BillionToOne, Inc. cfDNA Testing Product and Services
9.8.4 BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BillionToOne, Inc. Recent Developments/Updates
9.8.6 BillionToOne, Inc. Competitive Strengths & Weaknesses
9.9 ARUP Laboratories
9.9.1 ARUP Laboratories Details
9.9.2 ARUP Laboratories Major Business
9.9.3 ARUP Laboratories cfDNA Testing Product and Services
9.9.4 ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ARUP Laboratories Recent Developments/Updates
9.9.6 ARUP Laboratories Competitive Strengths & Weaknesses
9.10 Guardant Health
9.10.1 Guardant Health Details
9.10.2 Guardant Health Major Business
9.10.3 Guardant Health cfDNA Testing Product and Services
9.10.4 Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Guardant Health Recent Developments/Updates
9.10.6 Guardant Health Competitive Strengths & Weaknesses
9.11 GRAIL
9.11.1 GRAIL Details
9.11.2 GRAIL Major Business
9.11.3 GRAIL cfDNA Testing Product and Services
9.11.4 GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GRAIL Recent Developments/Updates
9.11.6 GRAIL Competitive Strengths & Weaknesses
9.12 Foundation Medicine
9.12.1 Foundation Medicine Details
9.12.2 Foundation Medicine Major Business
9.12.3 Foundation Medicine cfDNA Testing Product and Services
9.12.4 Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Foundation Medicine Recent Developments/Updates
9.12.6 Foundation Medicine Competitive Strengths & Weaknesses
9.13 MedGenome
9.13.1 MedGenome Details
9.13.2 MedGenome Major Business
9.13.3 MedGenome cfDNA Testing Product and Services
9.13.4 MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MedGenome Recent Developments/Updates
9.13.6 MedGenome Competitive Strengths & Weaknesses
9.14 Lucence
9.14.1 Lucence Details
9.14.2 Lucence Major Business
9.14.3 Lucence cfDNA Testing Product and Services
9.14.4 Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Lucence Recent Developments/Updates
9.14.6 Lucence Competitive Strengths & Weaknesses
9.15 BGI Genomics
9.15.1 BGI Genomics Details
9.15.2 BGI Genomics Major Business
9.15.3 BGI Genomics cfDNA Testing Product and Services
9.15.4 BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 BGI Genomics Recent Developments/Updates
9.15.6 BGI Genomics Competitive Strengths & Weaknesses
9.16 Berry Genomics
9.16.1 Berry Genomics Details
9.16.2 Berry Genomics Major Business
9.16.3 Berry Genomics cfDNA Testing Product and Services
9.16.4 Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Berry Genomics Recent Developments/Updates
9.16.6 Berry Genomics Competitive Strengths & Weaknesses
9.17 Burning Rock
9.17.1 Burning Rock Details
9.17.2 Burning Rock Major Business
9.17.3 Burning Rock cfDNA Testing Product and Services
9.17.4 Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Burning Rock Recent Developments/Updates
9.17.6 Burning Rock Competitive Strengths & Weaknesses
9.18 ACT Genomics
9.18.1 ACT Genomics Details
9.18.2 ACT Genomics Major Business
9.18.3 ACT Genomics cfDNA Testing Product and Services
9.18.4 ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 ACT Genomics Recent Developments/Updates
9.18.6 ACT Genomics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 cfDNA Testing Industry Chain
10.2 cfDNA Testing Upstream Analysis
10.3 cfDNA Testing Midstream Analysis
10.4 cfDNA Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 cfDNA Testing Introduction
1.2 World cfDNA Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World cfDNA Testing Total Market by Region (by Headquarter Location)
1.3.1 World cfDNA Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company cfDNA Testing Revenue (2021-2032)
1.3.3 China Based Company cfDNA Testing Revenue (2021-2032)
1.3.4 Europe Based Company cfDNA Testing Revenue (2021-2032)
1.3.5 Japan Based Company cfDNA Testing Revenue (2021-2032)
1.3.6 South Korea Based Company cfDNA Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company cfDNA Testing Revenue (2021-2032)
1.3.8 India Based Company cfDNA Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 cfDNA Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World cfDNA Testing Consumption Value (2021-2032)
2.2 World cfDNA Testing Consumption Value by Region
2.2.1 World cfDNA Testing Consumption Value by Region (2021-2026)
2.2.2 World cfDNA Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States cfDNA Testing Consumption Value (2021-2032)
2.4 China cfDNA Testing Consumption Value (2021-2032)
2.5 Europe cfDNA Testing Consumption Value (2021-2032)
2.6 Japan cfDNA Testing Consumption Value (2021-2032)
2.7 South Korea cfDNA Testing Consumption Value (2021-2032)
2.8 ASEAN cfDNA Testing Consumption Value (2021-2032)
2.9 India cfDNA Testing Consumption Value (2021-2032)
3 WORLD CFDNA TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World cfDNA Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global cfDNA Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for cfDNA Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for cfDNA Testing in 2025
3.3 cfDNA Testing Company Evaluation Quadrant
3.4 cfDNA Testing Market: Overall Company Footprint Analysis
3.4.1 cfDNA Testing Market: Region Footprint
3.4.2 cfDNA Testing Market: Company Product Type Footprint
3.4.3 cfDNA Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: cfDNA Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: cfDNA Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: cfDNA Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: cfDNA Testing Consumption Value Comparison
4.2.1 United States VS China: cfDNA Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: cfDNA Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based cfDNA Testing Companies and Market Share, 2021-2026
4.3.1 United States Based cfDNA Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies cfDNA Testing Revenue, (2021-2026)
4.4 China Based Companies cfDNA Testing Revenue and Market Share, 2021-2026
4.4.1 China Based cfDNA Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies cfDNA Testing Revenue, (2021-2026)
4.5 Rest of World Based cfDNA Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based cfDNA Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies cfDNA Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World cfDNA Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Sequencing
5.2.2 Whole Genome Sequencing
5.3 Market Segment by Type
5.3.1 World cfDNA Testing Market Size by Type (2021-2026)
5.3.2 World cfDNA Testing Market Size by Type (2027-2032)
5.3.3 World cfDNA Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEST TYPE
6.1 World cfDNA Testing Market Size Overview by Test Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Test Type
6.2.1 Services
6.2.2 Reagent Kits
6.2.3 Others
6.3 Market Segment by Test Type
6.3.1 World cfDNA Testing Market Size by Test Type (2021-2026)
6.3.2 World cfDNA Testing Market Size by Test Type (2027-2032)
6.3.3 World cfDNA Testing Market Size Market Share by Test Type (2027-2032)
7 MARKET ANALYSIS TARGET AUDIENCES
7.1 World cfDNA Testing Market Size Overview Target Audiences: 2021 VS 2025 VS 2032
7.2 Segment Introduction Target Audiences
7.2.1 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
7.2.2 DTC (Direct-to-Consumer) Services for Consumers
7.3 Market Segment Target Audiences
7.3.1 World cfDNA Testing Market Size Target Audiences (2021-2026)
7.3.2 World cfDNA Testing Market Size Target Audiences (2027-2032)
7.3.3 World cfDNA Testing Market Size Market Share Target Audiences (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World cfDNA Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Prenatal Testing
8.2.2 Oncology
8.2.3 Organ Transplant Monitoring
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World cfDNA Testing Market Size by Application (2021-2026)
8.3.2 World cfDNA Testing Market Size by Application (2027-2032)
8.3.3 World cfDNA Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 NIPT by LifeCodexx
9.1.1 NIPT by LifeCodexx Details
9.1.2 NIPT by LifeCodexx Major Business
9.1.3 NIPT by LifeCodexx cfDNA Testing Product and Services
9.1.4 NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 NIPT by LifeCodexx Recent Developments/Updates
9.1.6 NIPT by LifeCodexx Competitive Strengths & Weaknesses
9.2 Genodive Pharma
9.2.1 Genodive Pharma Details
9.2.2 Genodive Pharma Major Business
9.2.3 Genodive Pharma cfDNA Testing Product and Services
9.2.4 Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Genodive Pharma Recent Developments/Updates
9.2.6 Genodive Pharma Competitive Strengths & Weaknesses
9.3 Riken Genesis
9.3.1 Riken Genesis Details
9.3.2 Riken Genesis Major Business
9.3.3 Riken Genesis cfDNA Testing Product and Services
9.3.4 Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Riken Genesis Recent Developments/Updates
9.3.6 Riken Genesis Competitive Strengths & Weaknesses
9.4 GC Genome
9.4.1 GC Genome Details
9.4.2 GC Genome Major Business
9.4.3 GC Genome cfDNA Testing Product and Services
9.4.4 GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GC Genome Recent Developments/Updates
9.4.6 GC Genome Competitive Strengths & Weaknesses
9.5 EDGC
9.5.1 EDGC Details
9.5.2 EDGC Major Business
9.5.3 EDGC cfDNA Testing Product and Services
9.5.4 EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 EDGC Recent Developments/Updates
9.5.6 EDGC Competitive Strengths & Weaknesses
9.6 Natera
9.6.1 Natera Details
9.6.2 Natera Major Business
9.6.3 Natera cfDNA Testing Product and Services
9.6.4 Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Natera Recent Developments/Updates
9.6.6 Natera Competitive Strengths & Weaknesses
9.7 CareDx
9.7.1 CareDx Details
9.7.2 CareDx Major Business
9.7.3 CareDx cfDNA Testing Product and Services
9.7.4 CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CareDx Recent Developments/Updates
9.7.6 CareDx Competitive Strengths & Weaknesses
9.8 BillionToOne, Inc.
9.8.1 BillionToOne, Inc. Details
9.8.2 BillionToOne, Inc. Major Business
9.8.3 BillionToOne, Inc. cfDNA Testing Product and Services
9.8.4 BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BillionToOne, Inc. Recent Developments/Updates
9.8.6 BillionToOne, Inc. Competitive Strengths & Weaknesses
9.9 ARUP Laboratories
9.9.1 ARUP Laboratories Details
9.9.2 ARUP Laboratories Major Business
9.9.3 ARUP Laboratories cfDNA Testing Product and Services
9.9.4 ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ARUP Laboratories Recent Developments/Updates
9.9.6 ARUP Laboratories Competitive Strengths & Weaknesses
9.10 Guardant Health
9.10.1 Guardant Health Details
9.10.2 Guardant Health Major Business
9.10.3 Guardant Health cfDNA Testing Product and Services
9.10.4 Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Guardant Health Recent Developments/Updates
9.10.6 Guardant Health Competitive Strengths & Weaknesses
9.11 GRAIL
9.11.1 GRAIL Details
9.11.2 GRAIL Major Business
9.11.3 GRAIL cfDNA Testing Product and Services
9.11.4 GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GRAIL Recent Developments/Updates
9.11.6 GRAIL Competitive Strengths & Weaknesses
9.12 Foundation Medicine
9.12.1 Foundation Medicine Details
9.12.2 Foundation Medicine Major Business
9.12.3 Foundation Medicine cfDNA Testing Product and Services
9.12.4 Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Foundation Medicine Recent Developments/Updates
9.12.6 Foundation Medicine Competitive Strengths & Weaknesses
9.13 MedGenome
9.13.1 MedGenome Details
9.13.2 MedGenome Major Business
9.13.3 MedGenome cfDNA Testing Product and Services
9.13.4 MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MedGenome Recent Developments/Updates
9.13.6 MedGenome Competitive Strengths & Weaknesses
9.14 Lucence
9.14.1 Lucence Details
9.14.2 Lucence Major Business
9.14.3 Lucence cfDNA Testing Product and Services
9.14.4 Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Lucence Recent Developments/Updates
9.14.6 Lucence Competitive Strengths & Weaknesses
9.15 BGI Genomics
9.15.1 BGI Genomics Details
9.15.2 BGI Genomics Major Business
9.15.3 BGI Genomics cfDNA Testing Product and Services
9.15.4 BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 BGI Genomics Recent Developments/Updates
9.15.6 BGI Genomics Competitive Strengths & Weaknesses
9.16 Berry Genomics
9.16.1 Berry Genomics Details
9.16.2 Berry Genomics Major Business
9.16.3 Berry Genomics cfDNA Testing Product and Services
9.16.4 Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Berry Genomics Recent Developments/Updates
9.16.6 Berry Genomics Competitive Strengths & Weaknesses
9.17 Burning Rock
9.17.1 Burning Rock Details
9.17.2 Burning Rock Major Business
9.17.3 Burning Rock cfDNA Testing Product and Services
9.17.4 Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Burning Rock Recent Developments/Updates
9.17.6 Burning Rock Competitive Strengths & Weaknesses
9.18 ACT Genomics
9.18.1 ACT Genomics Details
9.18.2 ACT Genomics Major Business
9.18.3 ACT Genomics cfDNA Testing Product and Services
9.18.4 ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 ACT Genomics Recent Developments/Updates
9.18.6 ACT Genomics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 cfDNA Testing Industry Chain
10.2 cfDNA Testing Upstream Analysis
10.3 cfDNA Testing Midstream Analysis
10.4 cfDNA Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World cfDNA Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World cfDNA Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World cfDNA Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World cfDNA Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World cfDNA Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World cfDNA Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World cfDNA Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World cfDNA Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World cfDNA Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key cfDNA Testing Players in 2025
Table 12. World cfDNA Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global cfDNA Testing Company Evaluation Quadrant
Table 14. Head Office of Key cfDNA Testing Players
Table 15. cfDNA Testing Market: Company Product Type Footprint
Table 16. cfDNA Testing Market: Company Product Application Footprint
Table 17. cfDNA Testing Mergers & Acquisitions Activity
Table 18. United States VS China cfDNA Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China cfDNA Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based cfDNA Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies cfDNA Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 23. China Based cfDNA Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies cfDNA Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based cfDNA Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies cfDNA Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 29. World cfDNA Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World cfDNA Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World cfDNA Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World cfDNA Testing Market Size by Test Type, (USD Million), 2021 & 2025 & 2032
Table 33. World cfDNA Testing Market Size Value by Test Type (2021-2026) & (USD Million)
Table 34. World cfDNA Testing Market Size by Test Type (2027-2032) & (USD Million)
Table 35. World cfDNA Testing Market Size Target Audiences, (USD Million), 2021 & 2025 & 2032
Table 36. World cfDNA Testing Market Size Value Target Audiences (2021-2026) & (USD Million)
Table 37. World cfDNA Testing Market Size Target Audiences (2027-2032) & (USD Million)
Table 38. World cfDNA Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World cfDNA Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World cfDNA Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. NIPT by LifeCodexx Basic Information, Manufacturing Base and Competitors
Table 42. NIPT by LifeCodexx Major Business
Table 43. NIPT by LifeCodexx cfDNA Testing Product and Services
Table 44. NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. NIPT by LifeCodexx Recent Developments/Updates
Table 46. NIPT by LifeCodexx Competitive Strengths & Weaknesses
Table 47. Genodive Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Genodive Pharma Major Business
Table 49. Genodive Pharma cfDNA Testing Product and Services
Table 50. Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Genodive Pharma Recent Developments/Updates
Table 52. Genodive Pharma Competitive Strengths & Weaknesses
Table 53. Riken Genesis Basic Information, Manufacturing Base and Competitors
Table 54. Riken Genesis Major Business
Table 55. Riken Genesis cfDNA Testing Product and Services
Table 56. Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Riken Genesis Recent Developments/Updates
Table 58. Riken Genesis Competitive Strengths & Weaknesses
Table 59. GC Genome Basic Information, Manufacturing Base and Competitors
Table 60. GC Genome Major Business
Table 61. GC Genome cfDNA Testing Product and Services
Table 62. GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GC Genome Recent Developments/Updates
Table 64. GC Genome Competitive Strengths & Weaknesses
Table 65. EDGC Basic Information, Manufacturing Base and Competitors
Table 66. EDGC Major Business
Table 67. EDGC cfDNA Testing Product and Services
Table 68. EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EDGC Recent Developments/Updates
Table 70. EDGC Competitive Strengths & Weaknesses
Table 71. Natera Basic Information, Manufacturing Base and Competitors
Table 72. Natera Major Business
Table 73. Natera cfDNA Testing Product and Services
Table 74. Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Natera Recent Developments/Updates
Table 76. Natera Competitive Strengths & Weaknesses
Table 77. CareDx Basic Information, Manufacturing Base and Competitors
Table 78. CareDx Major Business
Table 79. CareDx cfDNA Testing Product and Services
Table 80. CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CareDx Recent Developments/Updates
Table 82. CareDx Competitive Strengths & Weaknesses
Table 83. BillionToOne, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. BillionToOne, Inc. Major Business
Table 85. BillionToOne, Inc. cfDNA Testing Product and Services
Table 86. BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BillionToOne, Inc. Recent Developments/Updates
Table 88. BillionToOne, Inc. Competitive Strengths & Weaknesses
Table 89. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 90. ARUP Laboratories Major Business
Table 91. ARUP Laboratories cfDNA Testing Product and Services
Table 92. ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ARUP Laboratories Recent Developments/Updates
Table 94. ARUP Laboratories Competitive Strengths & Weaknesses
Table 95. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 96. Guardant Health Major Business
Table 97. Guardant Health cfDNA Testing Product and Services
Table 98. Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Guardant Health Recent Developments/Updates
Table 100. Guardant Health Competitive Strengths & Weaknesses
Table 101. GRAIL Basic Information, Manufacturing Base and Competitors
Table 102. GRAIL Major Business
Table 103. GRAIL cfDNA Testing Product and Services
Table 104. GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GRAIL Recent Developments/Updates
Table 106. GRAIL Competitive Strengths & Weaknesses
Table 107. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 108. Foundation Medicine Major Business
Table 109. Foundation Medicine cfDNA Testing Product and Services
Table 110. Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Foundation Medicine Recent Developments/Updates
Table 112. Foundation Medicine Competitive Strengths & Weaknesses
Table 113. MedGenome Basic Information, Manufacturing Base and Competitors
Table 114. MedGenome Major Business
Table 115. MedGenome cfDNA Testing Product and Services
Table 116. MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MedGenome Recent Developments/Updates
Table 118. MedGenome Competitive Strengths & Weaknesses
Table 119. Lucence Basic Information, Manufacturing Base and Competitors
Table 120. Lucence Major Business
Table 121. Lucence cfDNA Testing Product and Services
Table 122. Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Lucence Recent Developments/Updates
Table 124. Lucence Competitive Strengths & Weaknesses
Table 125. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 126. BGI Genomics Major Business
Table 127. BGI Genomics cfDNA Testing Product and Services
Table 128. BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BGI Genomics Recent Developments/Updates
Table 130. BGI Genomics Competitive Strengths & Weaknesses
Table 131. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 132. Berry Genomics Major Business
Table 133. Berry Genomics cfDNA Testing Product and Services
Table 134. Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Berry Genomics Recent Developments/Updates
Table 136. Berry Genomics Competitive Strengths & Weaknesses
Table 137. Burning Rock Basic Information, Manufacturing Base and Competitors
Table 138. Burning Rock Major Business
Table 139. Burning Rock cfDNA Testing Product and Services
Table 140. Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Burning Rock Recent Developments/Updates
Table 142. Burning Rock Competitive Strengths & Weaknesses
Table 143. ACT Genomics Basic Information, Manufacturing Base and Competitors
Table 144. ACT Genomics Major Business
Table 145. ACT Genomics cfDNA Testing Product and Services
Table 146. ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. ACT Genomics Recent Developments/Updates
Table 148. ACT Genomics Competitive Strengths & Weaknesses
Table 149. Global Key Players of cfDNA Testing Upstream (Raw Materials)
Table 150. Global cfDNA Testing Typical Customers
Table 1. World cfDNA Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World cfDNA Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World cfDNA Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World cfDNA Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World cfDNA Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World cfDNA Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World cfDNA Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World cfDNA Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World cfDNA Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key cfDNA Testing Players in 2025
Table 12. World cfDNA Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global cfDNA Testing Company Evaluation Quadrant
Table 14. Head Office of Key cfDNA Testing Players
Table 15. cfDNA Testing Market: Company Product Type Footprint
Table 16. cfDNA Testing Market: Company Product Application Footprint
Table 17. cfDNA Testing Mergers & Acquisitions Activity
Table 18. United States VS China cfDNA Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China cfDNA Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based cfDNA Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies cfDNA Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 23. China Based cfDNA Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies cfDNA Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based cfDNA Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies cfDNA Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies cfDNA Testing Revenue Market Share (2021-2026)
Table 29. World cfDNA Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World cfDNA Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World cfDNA Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World cfDNA Testing Market Size by Test Type, (USD Million), 2021 & 2025 & 2032
Table 33. World cfDNA Testing Market Size Value by Test Type (2021-2026) & (USD Million)
Table 34. World cfDNA Testing Market Size by Test Type (2027-2032) & (USD Million)
Table 35. World cfDNA Testing Market Size Target Audiences, (USD Million), 2021 & 2025 & 2032
Table 36. World cfDNA Testing Market Size Value Target Audiences (2021-2026) & (USD Million)
Table 37. World cfDNA Testing Market Size Target Audiences (2027-2032) & (USD Million)
Table 38. World cfDNA Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World cfDNA Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World cfDNA Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. NIPT by LifeCodexx Basic Information, Manufacturing Base and Competitors
Table 42. NIPT by LifeCodexx Major Business
Table 43. NIPT by LifeCodexx cfDNA Testing Product and Services
Table 44. NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. NIPT by LifeCodexx Recent Developments/Updates
Table 46. NIPT by LifeCodexx Competitive Strengths & Weaknesses
Table 47. Genodive Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Genodive Pharma Major Business
Table 49. Genodive Pharma cfDNA Testing Product and Services
Table 50. Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Genodive Pharma Recent Developments/Updates
Table 52. Genodive Pharma Competitive Strengths & Weaknesses
Table 53. Riken Genesis Basic Information, Manufacturing Base and Competitors
Table 54. Riken Genesis Major Business
Table 55. Riken Genesis cfDNA Testing Product and Services
Table 56. Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Riken Genesis Recent Developments/Updates
Table 58. Riken Genesis Competitive Strengths & Weaknesses
Table 59. GC Genome Basic Information, Manufacturing Base and Competitors
Table 60. GC Genome Major Business
Table 61. GC Genome cfDNA Testing Product and Services
Table 62. GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GC Genome Recent Developments/Updates
Table 64. GC Genome Competitive Strengths & Weaknesses
Table 65. EDGC Basic Information, Manufacturing Base and Competitors
Table 66. EDGC Major Business
Table 67. EDGC cfDNA Testing Product and Services
Table 68. EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. EDGC Recent Developments/Updates
Table 70. EDGC Competitive Strengths & Weaknesses
Table 71. Natera Basic Information, Manufacturing Base and Competitors
Table 72. Natera Major Business
Table 73. Natera cfDNA Testing Product and Services
Table 74. Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Natera Recent Developments/Updates
Table 76. Natera Competitive Strengths & Weaknesses
Table 77. CareDx Basic Information, Manufacturing Base and Competitors
Table 78. CareDx Major Business
Table 79. CareDx cfDNA Testing Product and Services
Table 80. CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CareDx Recent Developments/Updates
Table 82. CareDx Competitive Strengths & Weaknesses
Table 83. BillionToOne, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. BillionToOne, Inc. Major Business
Table 85. BillionToOne, Inc. cfDNA Testing Product and Services
Table 86. BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BillionToOne, Inc. Recent Developments/Updates
Table 88. BillionToOne, Inc. Competitive Strengths & Weaknesses
Table 89. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 90. ARUP Laboratories Major Business
Table 91. ARUP Laboratories cfDNA Testing Product and Services
Table 92. ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ARUP Laboratories Recent Developments/Updates
Table 94. ARUP Laboratories Competitive Strengths & Weaknesses
Table 95. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 96. Guardant Health Major Business
Table 97. Guardant Health cfDNA Testing Product and Services
Table 98. Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Guardant Health Recent Developments/Updates
Table 100. Guardant Health Competitive Strengths & Weaknesses
Table 101. GRAIL Basic Information, Manufacturing Base and Competitors
Table 102. GRAIL Major Business
Table 103. GRAIL cfDNA Testing Product and Services
Table 104. GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GRAIL Recent Developments/Updates
Table 106. GRAIL Competitive Strengths & Weaknesses
Table 107. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 108. Foundation Medicine Major Business
Table 109. Foundation Medicine cfDNA Testing Product and Services
Table 110. Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Foundation Medicine Recent Developments/Updates
Table 112. Foundation Medicine Competitive Strengths & Weaknesses
Table 113. MedGenome Basic Information, Manufacturing Base and Competitors
Table 114. MedGenome Major Business
Table 115. MedGenome cfDNA Testing Product and Services
Table 116. MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MedGenome Recent Developments/Updates
Table 118. MedGenome Competitive Strengths & Weaknesses
Table 119. Lucence Basic Information, Manufacturing Base and Competitors
Table 120. Lucence Major Business
Table 121. Lucence cfDNA Testing Product and Services
Table 122. Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Lucence Recent Developments/Updates
Table 124. Lucence Competitive Strengths & Weaknesses
Table 125. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 126. BGI Genomics Major Business
Table 127. BGI Genomics cfDNA Testing Product and Services
Table 128. BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BGI Genomics Recent Developments/Updates
Table 130. BGI Genomics Competitive Strengths & Weaknesses
Table 131. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 132. Berry Genomics Major Business
Table 133. Berry Genomics cfDNA Testing Product and Services
Table 134. Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Berry Genomics Recent Developments/Updates
Table 136. Berry Genomics Competitive Strengths & Weaknesses
Table 137. Burning Rock Basic Information, Manufacturing Base and Competitors
Table 138. Burning Rock Major Business
Table 139. Burning Rock cfDNA Testing Product and Services
Table 140. Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Burning Rock Recent Developments/Updates
Table 142. Burning Rock Competitive Strengths & Weaknesses
Table 143. ACT Genomics Basic Information, Manufacturing Base and Competitors
Table 144. ACT Genomics Major Business
Table 145. ACT Genomics cfDNA Testing Product and Services
Table 146. ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. ACT Genomics Recent Developments/Updates
Table 148. ACT Genomics Competitive Strengths & Weaknesses
Table 149. Global Key Players of cfDNA Testing Upstream (Raw Materials)
Table 150. Global cfDNA Testing Typical Customers
LIST OF FIGURES
Figure 1. cfDNA Testing Picture
Figure 2. World cfDNA Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World cfDNA Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World cfDNA Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World cfDNA Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 13. cfDNA Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World cfDNA Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of cfDNA Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for cfDNA Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for cfDNA Testing Markets in 2025
Figure 27. United States VS China: cfDNA Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: cfDNA Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World cfDNA Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World cfDNA Testing Market Size Market Share by Type in 2025
Figure 31. Targeted Sequencing
Figure 32. Whole Genome Sequencing
Figure 33. World cfDNA Testing Market Size Market Share by Type (2021-2032)
Figure 34. World cfDNA Testing Market Size by Test Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World cfDNA Testing Market Size Market Share by Test Type in 2025
Figure 36. Services
Figure 37. Reagent Kits
Figure 38. Others
Figure 39. World cfDNA Testing Market Size Market Share by Test Type (2021-2032)
Figure 40. World cfDNA Testing Market Size Target Audiences, (USD Million), 2021 & 2025 & 2032
Figure 41. World cfDNA Testing Market Size Market Share Target Audiences in 2025
Figure 42. LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
Figure 43. DTC (Direct-to-Consumer) Services for Consumers
Figure 44. World cfDNA Testing Market Size Market Share Target Audiences (2021-2032)
Figure 45. World cfDNA Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World cfDNA Testing Market Size Market Share by Application in 2025
Figure 47. Prenatal Testing
Figure 48. Oncology
Figure 49. Organ Transplant Monitoring
Figure 50. Others
Figure 51. World cfDNA Testing Market Size Market Share by Application (2021-2032)
Figure 52. cfDNA Testing Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. cfDNA Testing Picture
Figure 2. World cfDNA Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World cfDNA Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World cfDNA Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World cfDNA Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company cfDNA Testing Revenue (2021-2032) & (USD Million)
Figure 13. cfDNA Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World cfDNA Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India cfDNA Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of cfDNA Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for cfDNA Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for cfDNA Testing Markets in 2025
Figure 27. United States VS China: cfDNA Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: cfDNA Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World cfDNA Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World cfDNA Testing Market Size Market Share by Type in 2025
Figure 31. Targeted Sequencing
Figure 32. Whole Genome Sequencing
Figure 33. World cfDNA Testing Market Size Market Share by Type (2021-2032)
Figure 34. World cfDNA Testing Market Size by Test Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World cfDNA Testing Market Size Market Share by Test Type in 2025
Figure 36. Services
Figure 37. Reagent Kits
Figure 38. Others
Figure 39. World cfDNA Testing Market Size Market Share by Test Type (2021-2032)
Figure 40. World cfDNA Testing Market Size Target Audiences, (USD Million), 2021 & 2025 & 2032
Figure 41. World cfDNA Testing Market Size Market Share Target Audiences in 2025
Figure 42. LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
Figure 43. DTC (Direct-to-Consumer) Services for Consumers
Figure 44. World cfDNA Testing Market Size Market Share Target Audiences (2021-2032)
Figure 45. World cfDNA Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World cfDNA Testing Market Size Market Share by Application in 2025
Figure 47. Prenatal Testing
Figure 48. Oncology
Figure 49. Organ Transplant Monitoring
Figure 50. Others
Figure 51. World cfDNA Testing Market Size Market Share by Application (2021-2032)
Figure 52. cfDNA Testing Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
